Hot penny stocks... don't get burned
   

News for Cell Genesys, Inc (CEGE)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Cell Genesys Inc.  (CEGE) 
|
$ 0.60      0.04 (+7.14%) Volume: 0 4:00 PM EDT Oct 6, 2008
Mon, Sep 15, 2008
8:44 AM Cell Genesys to Present at the UBS Global Life Sciences Conference - Business Wire
Thu, Sep 11, 2008
8:35 AM Cell Genesys Reconfirms Ongoing Plans with FDA for Phase 3 Program for GVAX Immunotherapy for Prostate Cancer While on Partial Clinical Hold - Business Wire
Tue, Sep 02, 2008
6:08 PM Cell Genesys to Present at the NewsMakers in the Biotech Industry Conference - Business Wire
Fri, Aug 29, 2008
10:51 AM BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD - PR Newswire
Wed, Aug 27, 2008
7:11 AM Cell Genesys Halts VITAL-2 GVAX Trial in Advanced Prostate Cancer - Business Wire
Wed, Aug 06, 2008
8:30 AM Cell Genesys to Present at the 28th Annual Canaccord Adams Global Growth Conference - Business Wire
Fri, Aug 01, 2008
4:01 PM Cell Genesys Reports Second Quarter 2008 Financial Results - Business Wire
Fri, Jul 25, 2008
8:31 AM Cell Genesys to Webcast Second Quarter 2008 Conference Call - Business Wire
Tue, Jul 22, 2008
8:43 AM Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer - Business Wire
Fri, Jun 27, 2008
10:00 AM BeaconEquity.com Issues TraderNotes on Active Stocks: SWHC, ARNA, BORL, QTWW, CSGH, FEED, BVN, CEGE - PR Newswire
Wed, Jun 04, 2008
8:39 AM Cell Genesys to Present at the Needham & Company Seventh Annual Biotechnology and Medical Technology Conference - Business Wire
Mon, Jun 02, 2008
10:59 AM TapImmune Inc. Rated 'Speculative Buy,' Target Price $0.85 by Beacon Equity Research - U.S. Equity News
8:22 AM Cell Genesys Reports Updated Results From Phase 1 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Used in Combination With Ipilimumab - Business Wire
Wed, May 21, 2008
8:09 AM Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer - Business Wire
Mon, May 12, 2008
4:01 PM Cell Genesys to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference - Business Wire
6:09 AM Cell Genesys Announces Registered Direct Equity Offering of $30 Million - Business Wire
Fri, May 02, 2008
8:34 AM Cell Genesys to Present at the Leerink Swann Solid Tumors Roundtable Conference - Business Wire
Thu, May 01, 2008
4:04 PM Cell Genesys Reports First Quarter 2008 Financial Results - Business Wire
Thu, Apr 24, 2008
8:57 AM Cell Genesys to Webcast First Quarter 2008 Conference Call - Business Wire
Wed, Apr 23, 2008
7:00 AM Ceregene Announces Two Key Additions to Leadership Team - PR Newswire
Tue, Apr 15, 2008
11:04 AM Cell Genesys Reports Data on an Association Between Immune Response and Anti-Tumor Activity in Patients Receiving GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) - Business Wire
Mon, Apr 14, 2008
4:01 PM Cell Genesys Reports Preclinical Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen Immunotherapies - Business Wire
Fri, Apr 11, 2008
4:41 PM Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of GVAX Immunotherapy for Prostate Cancer in Recurrent Disease - Business Wire
Wed, Apr 02, 2008
8:43 AM Breaking News Alert: OCOL! - Marketwire
Tue, Apr 01, 2008
10:40 AM BellwetherReport.com Free Analyst Review for CEGE, ITMN, ATHR and ORLY - Marketwire
  Page 1 of 3   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for CEGE stock. Download CEGE report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download CEGE report
  
Example preview: Research report for Cell Genesys, Inc (CEGE) Research report for Cell Genesys, Inc (CEGE) Research report for Cell Genesys, Inc (CEGE) Research report for Cell Genesys, Inc (CEGE)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Cell Genesys, Inc
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.